Treatment with infliximab for pediatric Crohn's disease: Nationwide survey of Japan-Reference-Cited by-同舟云学术

Treatment with infliximab for pediatric Crohn's disease: Nationwide survey of Japan

Published:2017-01 Issue:1 Volume:32 Page:114-119
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Hosoi Kenji¹,Ohtsuka Yoshikazu¹,Fujii Tohru¹,Kudo Takahiro¹,Matsunaga Nobuaki¹,Tomomasa Takeshi²,Tajiri Hitoshi³,Kunisaki Reiko⁴,Ishige Takashi⁵,Yamada Hiroyuki⁶,Arai Katsuhiro⁷,Yoden Atsushi⁸,Ushijima Kosuke⁹,Aomatsu Tomoki⁸,Nagata Satoru¹⁰,Uchida Keiichi¹¹,Takeuchi Kazuo¹²,Shimizu Toshiaki¹

Affiliation:

1. Department of Pediatrics and Adolescent Medicine; Juntendo University Graduate School of Medicine; Tokyo Japan

2. PAL Children's Clinic; Gunma Japan

3. Department of Pediatrics; Osaka General Medical Center; Osaka Japan

4. Inflammatory Bowel Centre; Yokohama City University Medical Centre; Yokohama Japan

5. Department of Pediatrics; Gunma University Graduate School of Medicine; Maebashi Japan

6. Department of Pediatric Gastroenterology, Nutrition and Endocrinology; Osaka Medical Center and Research Institute for Maternal and Child Health; Osaka Japan

7. Division of Gastroenterology; National Center for Child Health and Development; Tokyo Japan

8. Department of Pediatrics; Osaka Medical College; Osaka Japan

9. Department of Pediatrics; Kurume University Medical Center; Kurume Japan

10. Department of Pediatrics; Tokyo Women's Medical University Hospital; Tokyo Japan

11. Department of Gastrointestinal and Pediatric Surgery; Mie University Graduate School of Medicine; Mie Japan

12. General Health Support Center; Gunma University Graduate School of Medicine; Maebashi Japan

Funder

Health and Labour Sciences

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13498/fullpdf

Reference30 articles.

1. Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan;Ishige;J. Gastroenterol.,2010

2. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease;Herrinton;Am. J. Gastroenterol.,2011

3. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria;IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition;J. Pediatr. Gastroenterol. Nutr.,2005

4. Development and validation of a pediatric Crohn's disease activity index;Hyams;J. Pediatr. Gastroenterol. Nutr.,1991

5. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification;Levine;Inflamm. Bowel Dis.,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis;European Journal of Pediatrics;2024-01-19

2. The treatment of inflammatory bowel disease with monoclonal antibodies in Asia;Biomedicine & Pharmacotherapy;2023-01

3. Infliximab treatment of glycogenosis Ib with Crohn's-like enterocolitis: A case report;World Journal of Clinical Cases;2021-07-06

4. Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases: Results from a Clinical Practice Survey;Journal of Pediatric Gastroenterology & Nutrition;2019-05

5. Clinical presentation of Crohn’s, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes;Seminars in Pediatric Surgery;2017-12